Joinn Laboratories China Co Ltd
SSE:603127
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.46
28.56
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Joinn Laboratories China Co Ltd
Income from Continuing Operations
Joinn Laboratories China Co Ltd
Income from Continuing Operations Peer Comparison
603259
300759
2269
300347
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
J
|
Joinn Laboratories China Co Ltd
SSE:603127
|
Income from Continuing Operations
¥129.8m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Income from Continuing Operations
¥8.6B
|
CAGR 3-Years
30%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Income from Continuing Operations
¥1.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Income from Continuing Operations
¥3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Income from Continuing Operations
¥1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
15%
|
CAGR 10-Years
29%
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Income from Continuing Operations
¥283.5m
|
CAGR 3-Years
121%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Joinn Laboratories China Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
129.8m
CNY
Based on the financial report for Jun 30, 2024, Joinn Laboratories China Co Ltd's Income from Continuing Operations amounts to 129.8m CNY.
What is Joinn Laboratories China Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
1%
Over the last year, the Income from Continuing Operations growth was -84%. The average annual Income from Continuing Operations growth rates for Joinn Laboratories China Co Ltd have been -31% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
